XML 24 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Nov. 03, 2018
Oct. 28, 2017
Oct. 29, 2016
Cash flows from operating activities:      
Net Income $ 1,495,432 $ 727,259 $ 861,664
Adjustments to reconcile net income to net cash provided by operations:      
Depreciation 228,525 194,666 134,540
Amortization of intangibles 570,538 389,393 75,250
Cost of goods sold for inventory acquired 0 358,718 0
Stock-based compensation expense 151,165 104,188 63,421
Loss on extinguishment of debt 0 0 3,290
Other non-cash activity 36,569 (10,865) 24,570
Deferred income taxes (736,759) (825,869) 8,124
Change in operating assets and liabilities:      
Accounts receivable 45,979 (65,669) (9,392)
Inventories (34,636) (47,354) 38,221
Prepaid expenses and other current assets (1,721) (1,875) (5,618)
Deferred compensation plan investments (7,484) (7,358) (2,399)
Prepaid income tax 133 2,679 (4,315)
Accounts payable, deferred income and accrued liabilities (5,069) 192,249 85,502
Deferred compensation plan liability 7,484 7,358 2,399
Income taxes payable (3,903) 119,618 9,950
Other liabilities 696,108 17,227 6,141
Total adjustments 946,929 427,106 429,684
Net cash provided by operating activities 2,442,361 1,154,365 1,291,348
Cash flows from investing:      
Purchases of short-term available-for-sale investments 0 705,485 7,697,260
Maturities of short-term available-for-sale investments 0 3,362,792 6,375,361
Sales of short-term available-for-sale investments 0 577,187 332,716
Additions to property, plant and equipment, net (254,876) (204,098) (127,397)
Payments for acquisitions, net of cash acquired (52,839) (9,632,568) (83,170)
Change in other assets (6,283) (15,842) (18,520)
Net cash used for investing activities (313,998) (6,618,014) (1,218,270)
Cash flows from financing activities:      
Proceeds from debt 743,778 11,156,164 1,235,331
Debt repayments (2,275,000) (5,050,000) 0
Early termination of debt 0 0 (378,156)
Proceeds from (payments of) derivative instruments 0 3,904 (33,430)
Payments of deferred financing fees 0 (5,625) (26,583)
Dividend payments to shareholders (703,307) (602,119) (513,180)
Repurchase of common stock (225,977) (46,533) (370,061)
Proceeds from employee stock plans 99,027 133,302 61,496
Contingent consideration payment (2,890) (1,764) (1,409)
Change in other financing activities 6,327 (524) (7,378)
Net cash (used for) provided by financing activities (2,358,042) 5,586,805 (33,370)
Effect of exchange rate changes on cash (1,568) 3,550 (2,929)
Net (decrease) increase in cash and cash equivalents (231,247) 126,706 36,779
Cash and cash equivalents at beginning of year 1,047,838 921,132 884,353
Cash and cash equivalents at end of year $ 816,591 $ 1,047,838 $ 921,132